Ms. Schmier has worked in the outcomes research field for more than 15 years. She has substantial expertise in quality of life assessment and instrument validation, outcomes research, modeling, and health economics. She has published and presented studies in medical areas including asthma and other respiratory conditions, oncology, infectious diseases, psychiatry, hypertension, and neurological and digestive diseases. Particular areas of interest include compliance with treatment, electronic data collection, and the use of novel methodologies in patient preference and utility assessment.
Prior to joining Exponent, Ms. Schmier was a project manager at MEDTAP International, Inc., (now a division of United Biosource Corporation), where her work included quality of life and pharmacoeconomic study design and implementation as well as study and site management.